{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:46:20Z","timestamp":1790682380560,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"9b","license":[{"start":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T00:00:00Z","timestamp":1264723200000},"content-version":"vor","delay-in-days":150,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumour\u2010induced myeloid\u2010derived suppressor cells (MDSC) promote immune suppression and mediate tumour progression. However, the molecular basis for the generation of MDSC, which in mice co\u2010express the CD11b<jats:sup>+<\/jats:sup> and Gr\u20101<jats:sup>+<\/jats:sup> cell surface markers remains unclear. Because CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cells expand during progressive tumour growth, this suggests that tumour\u2010induced events alter signalling pathways that affect normal myeloid cell development. Interferon regulatory factor\u20108 (IRF\u20108), a member of the IFN\u2010\u03b3 regulatory factor family, is essential for normal myelopoiesis. We therefore examined whether IRF\u20108 modulated tumour\u2010induced CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cell development or accumulation using both implantable (4T1) and transgenic (MMTV\u2010PyMT) mouse models of mammary tumour growth. In the 4T1 model, both splenic and bone marrow\u2010derived CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cells of tumour\u2010bearing mice displayed a marked reduction in IRF\u20108 expression compared to control populations. A causal link between IRF\u20108 expression and the emergence of tumour\u2010induced CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cells was explored <jats:italic>in vivo<\/jats:italic> using a double transgenic (dTg) mouse model designed to express transgenes for both IRF\u20108 and mammary carcinoma development. Despite the fact that tumour growth was unaffected, splenomegaly, as well as the frequencies and absolute numbers of CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cells were significantly lower in dTg mice when compared with single transgenic tumour\u2010bearing mice. Overall, these data reveal that IRF\u20108 plays an important role in tumour\u2010induced development and\/or accumulation of CD11b<jats:sup>+<\/jats:sup>Gr\u20101<jats:sup>+<\/jats:sup> cells, and establishes a molecular basis for the potential manipulation of these myeloid populations for cancer therapy.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2009.00685.x","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T15:19:24Z","timestamp":1264691964000},"page":"3939-3950","source":"Crossref","is-referenced-by-count":43,"title":["Interferon regulatory factor\u20108 modulates the development of tumour\u2010induced CD11b<sup>+<\/sup>Gr\u20101<sup>+<\/sup> myeloid cells"],"prefix":"10.1111","volume":"13","author":[{"given":"Trina J.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Greeneltch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Liewehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott I.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm976"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141609"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399407000233"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-72005-0_22"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-005-0048-z"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.678"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5829"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2197"},{"key":"e_1_2_6_10_2","first-page":"4756","article-title":"Activated granulocytes and granulocyte\u2010derived hydrogen peroxide are the underlying mechanism of suppression of t\u2010cell function in advanced cancer patients","volume":"61","author":"Schmielau J","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4505"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022227"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1668"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.08.031"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830180109056724"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3007"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1261"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81348-3"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03556-1"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999002753452755"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.3.411"},{"key":"e_1_2_6_22_2","first-page":"1399","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor","volume":"52","author":"Aslakson CJ","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2354"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4666"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.12.3.954"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.5.2851"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701708419"},{"key":"e_1_2_6_28_2","first-page":"8298","article-title":"Transgenic polyoma middle\u2010T mice model premalignant mammary disease","volume":"61","author":"Maglione JE","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63568-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0912"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2003.01656.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2003.12.001"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0757"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.1.271"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1299"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.977"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050715"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4174"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.1.464"},{"key":"e_1_2_6_40_2","first-page":"4441","article-title":"All\u2010trans\u2010retinoic acid eliminates immature myeloid cells from tumor\u2010bearing mice and improves the effect of vaccination","volume":"63","author":"Kusmartsev S","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061104"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409783102"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0883"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1323"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2009.00685.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2009.00685.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T11:44:06Z","timestamp":1696160646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2009.00685.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":43,"journal-issue":{"issue":"9b","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1582-4934.2009.00685.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00685.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}